Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature

Archives of Pediatrics & Adolescent Medicine
Joyce M LeeAlex R Kemper

Abstract

To estimate the cost-effectiveness of growth hormone (GH) therapy for idiopathic short stature (ISS). Cost-effectiveness analysis. Decision model. A cohort of 10-year-old prepubertal boys with ISS treated with GH. Comparison of children treated for 5 years with GH therapy vs children receiving no intervention. Incremental cost per child, incremental growth per child, and incremental cost per inch of final height gain. The estimated incremental cost-effectiveness ratio of GH therapy for ISS in the base case analysis compared with no therapy was 52,634 dollars per inch (per 2.54 cm), or 99,959 dollars per child, reflecting an incremental growth of 1.9 in (4.8 cm). Alternate treatment strategies such as increased duration of GH treatment and high pubertal dosing of GH did not substantially improve the cost-effectiveness ratio. Probabilistic sensitivity analyses showed that growth variability in response to GH had the greatest impact on the cost-effectiveness of GH therapy. Targeted treatment of children with ISS with the greatest potential for growth appears critical for maximizing cost-effectiveness of GH treatment. However, the significance of the cost per inch is difficult to judge until the utility gains associated with height...Continue Reading

Citations

Jun 14, 2013·European Journal of Endocrinology·P ClaytonC Olivier
Mar 13, 2008·The Journal of Clinical Endocrinology and Metabolism·Adda GrimbergMichael P Wajnrajch
Dec 4, 2009·International Journal of Pediatric Endocrinology·Arlan L Rosenbloom
Apr 30, 2010·The Journal of Clinical Endocrinology and Metabolism·Leona Cuttler, J B Silvers
Jul 16, 2010·Biologics : Targets & Therapy·J Paul Frindik, Stephen F Kemp
Oct 4, 2011·Drug Design, Development and Therapy·Stephen F Kemp, J Paul Frindik
Apr 13, 2012·American Journal of Epidemiology·Andrew G RenehanPeter E Clayton
Jun 16, 2006·The New England Journal of Medicine·Mary M Lee
Dec 23, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·L Soriano-Guillén, J Argente
Jan 8, 2008·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·J M WitP Cohen
Aug 29, 2007·Pediatric Clinics of North America·Sergio R R Buzzini
May 16, 2012·Journal of Paediatrics and Child Health·Geoffrey R AmblerDominic J C Wilkinson
Feb 8, 2011·Journal for Specialists in Pediatric Nursing : JSPN·Monali BhosleWon Chan Lee
Feb 5, 2015·Journal of Diabetes and Metabolic Disorders·Ozra Tabatabaei-MalazyBagher Larijani
Sep 24, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Adda GrimbergCatherine M Gordon
Oct 29, 2008·Annales d'endocrinologie·F CastinettiT Brue
Mar 29, 2013·The New England Journal of Medicine·David B Allen, Leona Cuttler
Jun 10, 2015·Scientific Reports·Adda GrimbergVirginia A Stallings
Oct 9, 2015·The Cochrane Database of Systematic Reviews·Niamh McGrath, Michael J O'Grady
Jul 20, 2007·The Cochrane Database of Systematic Reviews·J BryantR Milne
Jul 31, 2014·International Journal of Pediatric Endocrinology·Juan F Sotos, Naomi J Tokar
Aug 27, 2010·Indian Journal of Pediatrics·B Adhisivam, S Srinivasan
Jan 27, 2007·Proceedings·William C Roberts
Nov 19, 2011·Indian Journal of Pediatrics·Nidhi MaheshwariLeona Cuttler
Feb 1, 2017·The Journal of Consumer Research·Detelina MarinovaJ B Silvers
Jun 11, 2008·Journal of Pediatric Endocrinology & Metabolism : JPEM·R RaaijmakersB J Otten
Sep 18, 2008·Arquivos brasileiros de endocrinologia e metabologia·Carlos Alberto Longui
Jan 24, 2007·Pediatric Annals·Rebecca S Farber, James R Kerrigan
May 12, 2021·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Philippe BackeljauwMehul T Dattani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.